XML 29 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders' Equity
 9 Months Ended
Sep. 30, 2017
Stockholders' Equity  
Stockholders' Equity

9. Stockholders’ Equity

 

Reconciliation of Outstanding Common Shares

 

 

 

For the nine months ended September 30,

 

 

 

2017

 

2016

 

 

 

(in millions)

 

Beginning balance

 
287.7

 
291.4

 

Shares issued

 
4.3

 
2.5

 

Treasury stock acquired

 
(3.5)

 
(6.2)

 

 

 

 

 

 

 

Ending balance

 
288.5

 
287.7

 

 

 

 

 

 

 

 

In October 2015, our Board of Directors authorized a share repurchase program of up to $150.0 million of our outstanding common stock, which was completed in March 2016. In February 2016, our Board of Directors authorized a share repurchase program of up to $400.0 million of our outstanding common stock. In May 2017, our Board of Directors authorized a share repurchase program of up to $250.0 million of our outstanding common stock. Shares repurchased under these programs are accounted for as treasury stock, carried at cost and reflected as a reduction to stockholders’ equity.

 

Other Comprehensive Income

 

 

 

For the three months ended

 

For the nine months ended

 

 

 

September 30, 2017

 

September 30, 2017

 

 

 

Pre-Tax

 

Tax

 

After-Tax

 

Pre-Tax

 

Tax

 

After-Tax

 

 

 

(in millions)

 

Net unrealized gains on available-for-sale securities during the period

 

$
137.3

 

$
(52.6)

 

$
84.7

 

$
1,044.2

 

$
(365.9)

 

$
678.3

 

Reclassification adjustment for losses included in net income (1)

 
0.3

 
0.2

 
0.5

 
49.9

 
(17.0)

 
32.9

 

Adjustments for assumed changes in amortization patterns

 
(0.2)

 
(0.1)

 
(0.3)

 
(48.4)

 
16.9

 
(31.5)

 

Adjustments for assumed changes in policyholder liabilities

 
(23.7)

 
8.9

 
(14.8)

 
(167.2)

 
56.6

 
(110.6)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net unrealized gains on available-for-sale securities

 
113.7

 
(43.6)

 
70.1

 
878.5

 
(309.4)

 
569.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Noncredit component of impairment losses on fixed maturities, available-for-sale during the period

 
19.2

 
(5.1)

 
14.1

 
32.5

 
(9.8)

 
22.7

 

Adjustments for assumed changes in amortization patterns

 
(1.0)

 
0.4

 
(0.6)

 
(2.1)

 
0.8

 
(1.3)

 

Adjustments for assumed changes in policyholder liabilities

 
(0.2)

 

—

 
(0.2)

 
(0.6)

 
0.2

 
(0.4)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Noncredit component of impairment losses on fixed maturities, available-for-sale (2)

 
18.0

 
(4.7)

 
13.3

 
29.8

 
(8.8)

 
21.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net unrealized losses on derivative instruments during the period

 
(17.0)

 
5.9

 
(11.1)

 
(32.5)

 
11.1

 
(21.4)

 

Reclassification adjustment for gains included in net income (3)

 
(2.5)

 
0.8

 
(1.7)

 
(21.0)

 
7.2

 
(13.8)

 

Adjustments for assumed changes in amortization patterns

 
0.6

 
(0.2)

 
0.4

 
2.6

 
(0.9)

 
1.7

 

Adjustments for assumed changes in policyholder liabilities

 
1.9

 
(0.6)

 
1.3

 
6.3

 
(2.1)

 
4.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net unrealized losses on derivative instruments

 
(17.0)

 
5.9

 
(11.1)

 
(44.6)

 
15.3

 
(29.3)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustment

 
95.7

 
(7.1)

 
88.6

 
155.3

 
(4.0)

 
151.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization of amounts included in net periodic benefit cost (4)

 
7.7

 
(3.5)

 
4.2

 
23.3

 
(10.5)

 
12.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net unrecognized postretirement benefit obligation

 
7.7

 
(3.5)

 
4.2

 
23.3

 
(10.5)

 
12.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive income

 

$
218.1

 

$
(53.0)

 

$
165.1

 

$
1,042.3

 

$
(317.4)

 

$
724.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the three months ended

 

For the nine months ended

 

 

 

September 30, 2016

 

September 30, 2016

 

 

 

Pre-Tax

 

Tax

 

After-Tax

 

Pre-Tax

 

Tax

 

After-Tax

 

 

 

(in millions)

 

Net unrealized gains on available-for-sale securities during the period

 

$
312.3

 

$
(96.2)

 

$
216.1

 

$
2,178.4

 

$
(739.7)

 

$
1,438.7

 

Reclassification adjustment for (gains) losses included in net income (1)

 
0.6

 
(2.2)

 
(1.6)

 
20.6

 
(9.2)

 
11.4

 

Adjustments for assumed changes in amortization patterns

 
(7.6)

 
2.6

 
(5.0)

 
(119.7)

 
41.9

 
(77.8)

 

Adjustments for assumed changes in policyholder liabilities

 
(126.5)

 
37.3

 
(89.2)

 
(813.7)

 
269.3

 
(544.4)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net unrealized gains on available-for-sale securities

 
178.8

 
(58.5)

 
120.3

 
1,265.6

 
(437.7)

 
827.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Noncredit component of impairment losses on fixed maturities, available-for-sale during the period

 
(10.7)

 
3.4

 
(7.3)

 
(11.6)

 
3.7

 
(7.9)

 

Adjustments for assumed changes in amortization patterns

 
2.1

 
(0.7)

 
1.4

 
0.5

 
(0.1)

 
0.4

 

Adjustments for assumed changes in policyholder liabilities

 
0.9

 
(0.3)

 
0.6

 
0.9

 
(0.3)

 
0.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Noncredit component of impairment losses on fixed maturities, available-for-sale (2)

 
(7.7)

 
2.4

 
(5.3)

 
(10.2)

 
3.3

 
(6.9)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net unrealized gains (losses) on derivative instruments during the period

 
(1.2)

 
0.3

 
(0.9)

 
20.7

 
(7.3)

 
13.4

 

Reclassification adjustment for gains included in net income (3)

 
(2.6)

 
0.9

 
(1.7)

 
(8.7)

 
2.7

 
(6.0)

 

Adjustments for assumed changes in amortization patterns

 
0.4

 
(0.2)

 
0.2

 
1.4

 
(0.5)

 
0.9

 

Adjustments for assumed changes in policyholder liabilities

 
9.5

 
(3.4)

 
6.1

 
12.2

 
(4.3)

 
7.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net unrealized gains on derivative instruments

 
6.1

 
(2.4)

 
3.7

 
25.6

 
(9.4)

 
16.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustment

 
(21.4)

 
5.4

 
(16.0)

 
142.6

 
(14.8)

 
127.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization of amounts included in net periodic benefit cost (4)

 
13.6

 
(5.6)

 
8.0

 
41.0

 
(17.0)

 
24.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net unrecognized postretirement benefit obligation

 
13.6

 
(5.6)

 
8.0

 
41.0

 
(17.0)

 
24.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive income

 

$
169.4

 

$
(58.7)

 

$
110.7

 

$
1,464.6

 

$
(475.6)

 

$
989.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)

Pre-tax reclassification adjustments relating to available-for-sale securities are reported in net realized capital gains (losses) on the consolidated statements of operations.

(2)

Represents the net impact of (1) unrealized gains resulting from reclassification of previously recognized noncredit impairment losses from OCI to net realized capital gains (losses) for fixed maturities with bifurcated OTTI that had additional credit losses or fixed maturities that previously had bifurcated OTTI that have now been sold or are intended to be sold and (2) unrealized losses resulting from reclassification of noncredit impairment losses for fixed maturities with bifurcated OTTI from net realized capital gains (losses) to OCI.

(3)

See Note 4, Derivative Financial Instruments – Cash Flow Hedges, for further details.

(4)

Amount is comprised of amortization of prior service cost (benefit) and recognized net actuarial (gain) loss, which is reported in operating expenses on the consolidated statements of operations. See Note 7, Employee and Agent Benefits – Components of Net Periodic Benefit Cost, for further details.

 

Accumulated Other Comprehensive Income (Loss)

 

 

 

 

 

Noncredit

 

 

 

 

 

 

 

 

 

 

 

Net unrealized

 

component of

 

Net unrealized

 

Foreign

 

Unrecognized

 

Accumulated

 

 

 

gains on

 

impairment losses

 

gains

 

currency

 

postretirement

 

other

 

 

 

available-for-sale

 

on fixed maturities

 

on derivative

 

translation

 

benefit

 

comprehensive

 

 

 

securities

 

available-for-sale

 

instruments

 

adjustment

 

obligation

 

income (loss)

 

 

 

(in millions)

 

Balances as of January 1, 2016

 

$
732.1

 

$
(86.0)

 

$
69.8

 

$
(1,148.2)

 

$
(450.2)

 

$
(882.5)

 

Other comprehensive income during the period, net of adjustments

 
816.5

 
(6.9)

 
22.2

 
122.4

 

—

 
954.2

 

Amounts reclassified from AOCI

 
11.4

 

—

 
(6.0)

 

—

 
24.0

 
29.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive income

 
827.9

 
(6.9)

 
16.2

 
122.4

 
24.0

 
983.6

 

Purchase of subsidiary shares from noncontrolling interest

 

—

 

—

 

—

 
(9.3)

 

—

 
(9.3)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances as of September 30, 2016

 

$
1,560.0

 

$
(92.9)

 

$
86.0

 

$
(1,035.1)

 

$
(426.2)

 

$
91.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances as of January 1, 2017

 

$
831.2

 

$
(89.5)

 

$
85.3

 

$
(1,093.8)

 

$
(408.4)

 

$
(675.2)

 

Other comprehensive income during the period, net of adjustments

 
536.2

 

—

 
(15.5)

 
148.6

 

—

 
669.3

 

Amounts reclassified from AOCI

 
32.9

 
21.0

 
(13.8)

 

—

 
12.8

 
52.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive income

 
569.1

 
21.0

 
(29.3)

 
148.6

 
12.8

 
722.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances as of September 30, 2017

 

$
1,400.3

 

$
(68.5)

 

$
56.0

 

$
(945.2)

 

$
(395.6)

 

$
47.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Noncontrolling Interest

 

Interests held by unaffiliated parties in consolidated entities are reflected in noncontrolling interest, which represents the noncontrolling partners’ share of the underlying net assets of our consolidated subsidiaries. Noncontrolling interest that is not redeemable is reported in the equity section of the consolidated statements of financial position.

 

The noncontrolling interest holders in certain of our consolidated entities maintain an equity interest that is redeemable at the option of the holder, which may be exercised on varying dates. Since redemption of the noncontrolling interest is outside of our control, this interest is presented on the consolidated statements of financial position line item titled “Redeemable noncontrolling interest.” Our redeemable noncontrolling interest primarily relates to consolidated sponsored investment funds for which interests are redeemed at fair value from the net assets of the funds.

 

For our redeemable noncontrolling interest related to other consolidated subsidiaries, redemptions are required to be purchased at fair value or a value based on a formula that management intended to reasonably approximate fair value based on a fixed multiple of earnings over a measurement period. The carrying value of the redeemable noncontrolling interest is compared to the redemption value at each reporting period. Any adjustments to the carrying amount of the redeemable noncontrolling interest for changes in redemption value prior to exercise of the redemption option are determined after the attribution of net income or loss of the subsidiary and are recognized in the redemption value as they occur. Adjustments to the carrying value of redeemable noncontrolling interest result in adjustments to additional paid-in capital and/or retained earnings. Adjustments are recorded in retained earnings to the extent the redemption value of the redeemable noncontrolling interest exceeds its fair value and will impact the numerator in our earnings per share calculations. All other adjustments to the redeemable noncontrolling interest are recorded in additional paid-in capital.

 

Following is a reconciliation of the changes in the redeemable noncontrolling interest (in millions):

 

Balance as of January 1, 2016

 

$
85.7

 

Net income attributable to redeemable noncontrolling interest

 
20.8

 

Redeemable noncontrolling interest of newly consolidated entities (1)

 
179.5

 

Redeemable noncontrolling interest of deconsolidated entities (2)

 
(181.2)

 

Contributions from redeemable noncontrolling interest

 
132.5

 

Distributions to redeemable noncontrolling interest

 
(46.9)

 

Purchase of subsidiary shares from redeemable noncontrolling interest

 
(8.2)

 

Change in redemption value of redeemable noncontrolling interest

 
4.1

 

Other comprehensive income attributable to redeemable noncontrolling interest

 
3.6

 

 

 

 

 

Balance as of September 30, 2016

 

$
189.9

 

 

 

 

 

 

 

 

 

 

Balance as of January 1, 2017

 

$
97.5

 

Net income attributable to redeemable noncontrolling interest

 
6.9

 

Redeemable noncontrolling interest of deconsolidated entities (2)

 
(1.4)

 

Contributions from redeemable noncontrolling interest

 
54.5

 

Distributions to redeemable noncontrolling interest

 
(28.2)

 

Purchase of subsidiary shares from redeemable noncontrolling interest

 
(4.4)

 

Change in redemption value of redeemable noncontrolling interest

 
2.8

 

Other comprehensive income attributable to redeemable noncontrolling interest

 
1.4

 

 

 

 

 

Balance as of September 30, 2017

 

$
129.1

 

 

 

 

 

 

 

(1)

Effective January 1, 2016, certain sponsored investment funds were consolidated as a result of the implementation of new accounting guidance.

(2)

We deconsolidated certain sponsored investment funds as they no longer met the requirements for consolidation.

 

Dividend Limitations

 

Under Iowa law, Principal Life may pay dividends only from the earned surplus arising from its business and must receive the prior approval of the Commissioner of Insurance of the State of Iowa (“the Commissioner”) to pay stockholder dividends or make any other distribution if such dividends or distributions would exceed certain statutory limitations. Iowa law gives the Commissioner discretion to disapprove requests for distributions in excess of these limitations. Extraordinary dividends include those made, together with dividends and other distributions, within the preceding twelve months that exceed the greater of (i) 10% of Principal Life’s statutory policyholder surplus as of the previous year-end or (ii) the statutory net gain from operations from the previous calendar year, not to exceed earned surplus. Based on December 31, 2016, statutory results, the dividend limitation for Principal Life is approximately $1,143.3 million in ordinary dividends in 2017 without prior regulatory approval. However, because the dividend test is based on dividends previously paid over rolling 12-month periods, if paid before a specified date during 2017, some or all of such dividends may be extraordinary and require regulatory approval.

 

On May 1, 2017, Principal Life sold its ownership interest in Principal Global Investors, LLC to Principal Life’s direct parent, Principal Financial Services, Inc. in connection with a corporate reorganization designed to better utilize and allocate capital internally. Subsequent to the sale, Principal Life paid an extraordinary dividend of $1,068.4 million to its parent, which was approved by the Commissioner, primarily from proceeds received from the sale.